PP405 Gel for Male Pattern Baldness

(AWAKEN Trial)

This trial tests a new gel treatment, PP405, for men with male pattern baldness. The goal is to determine the gel's long-term effectiveness and safety. Participants will apply either the PP405 gel or a placebo (a substance with no therapeutic effect) to their scalp for up to 52 weeks. Men who have experienced male pattern baldness for at least six months and have noticeable hair thinning may qualify for this study. As a Phase 2, Phase 3 trial, the study measures the treatment's effectiveness in a larger group and represents the final step before FDA approval. Participants have the opportunity to contribute to the development of a potentially groundbreaking solution.

The trial protocol does not clearly specify if you need to stop taking your current medications. However, it mentions that certain medications and procedures are excluded, so it's best to discuss your specific medications with the trial team.

Research has shown that PP405 0.05% Topical Gel is safe, based on earlier studies. Participants experienced significant improvements in hair thickness, with some studies reporting a 73% increase after 16 weeks, and no side effects were noted. Other research indicates that PP405 is well-tolerated, with no major side effects or absorption into the body. This suggests the treatment is generally safe for people, as previous research has not identified any serious side effects.¹²³⁴⁵

Unlike other treatments for male pattern baldness, which often involve oral medications like finasteride or topical solutions such as minoxidil, PP405 Gel is a topical treatment with a unique formulation. Researchers are excited about PP405 because it contains a new active ingredient designed to be applied directly to the scalp, potentially minimizing systemic side effects associated with oral treatments. Additionally, the gel's formulation may enhance absorption and efficacy, offering a promising alternative for those seeking an effective yet easy-to-apply solution for hair regrowth.

Research has shown that the PP405 0.05% gel holds promise for treating male pattern baldness. Participants in this trial will receive either the PP405 gel or a vehicle gel as a placebo comparator. One study found that 31% of men with significant hair loss experienced more than a 20% increase in hair density using PP405. Another study reported an average 73% increase in hair density after just 16 weeks of gel use. The gel activates hair follicle cells responsible for hair growth. Early results also suggest that the treatment helps prevent further hair loss, helping to maintain existing hair.⁶⁷⁸⁹¹⁰